NCT00170443View on ClinicalTrials.gov

Trivalent rHA Dose Escalation Study in Elderly Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2004

Conditions
Influenza
Interventions
BIOLOGICAL

rHAO Trivalent Influenza Vaccine

Trial Locations (3)

14642

University of Rochester, Rochester

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

77030

Baylor College of Medicine, Houston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00170443 - Trivalent rHA Dose Escalation Study in Elderly Subjects | Biotech Hunter | Biotech Hunter